The Combination of 3-Hydrazinoquinoxaline-2-Thiol with Thymoquinone Demonstrates Synergistic Activity Against Different Candida Strains

References

• Blumberg HM, Jarvis W, Soucie J, et al. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. Clin Infect Dis. 2001;33:177–186. doi:10.1086/321811
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007;20:133–163. doi:10.1128/CMR.00029-06
   PubMed Web of Science ®Google Scholar
• Rayens E, Norris KA, Cordero JCDSF. Mortality trends in risk conditions and invasive mycotic disease in the United States, 1999–2018. Clin Infect Dis. 2022;74:309–318. doi:10.1093/cid/ciab336
   PubMed Web of Science ®Google Scholar
• Rayens E, Norris KA. Prevalence and healthcare burden of fungal infections in the United States, 2018. Open Forum Infect Dis. 2022;9. doi:10.1093/ofid/ofab593
   PubMed Web of Science ®Google Scholar
• Benedict K, Jackson BR, Chiller T, B KD. Estimation of direct healthcare costs of fungal diseases in the United States. Clin Infect Dis. 2019;68:1791–1797. doi:10.1093/cid/ciy776
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Andes DR, Diekema DJ, et al. Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2496 patients: data from the prospective antifungal therapy (PATH) registry 2004–2008. PLoS One. 2014;9:e101510. doi:10.1371/journal.pone.0101510
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Messer SA, Woosley LN, Jones RN, Castanheira M. Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic. J Clin Microbiol. 2013;51:2571–2581. doi:10.1128/JCM.00308-13
   PubMed Web of Science ®Google Scholar
• Lockhart SR, Etienne KA, Vallabhaneni S, et al. Simultaneous emergence of multidrug-resistant candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis. 2017;64:134–140. doi:10.1093/cid/ciw691
   PubMed Web of Science ®Google Scholar
• Ksiezopolska E, Gabaldón T. Evolutionary emergence of drug resistance in candida opportunistic pathogens. Genes. 2018;9:461. doi:10.3390/genes9090461
   PubMed Web of Science ®Google Scholar
• Mota Fernandes C, Dasilva D, Haranahalli K, et al. The future of antifungal drug therapy: novel compounds and targets. Antimicrob Agents Chemother. 2021;65:1–13. doi:10.1128/AAC.01719-20
   Web of Science ®Google Scholar
• Parente-Rocha JA, Bailão AM, Amaral AC, et al. Antifungal resistance, metabolic routes as drug targets, and new antifungal agents: an overview about endemic dimorphic fungi. Mediators Inflamm. 2017;2017:1–16. doi:10.1155/2017/9870679
   Web of Science ®Google Scholar
• Miceli MH, Kauffman CA. Isavuconazole: a new broad-spectrum triazole antifungal agent. Clin Infect Dis. 2015;61:1558–1565. doi:10.1093/cid/civ571
   PubMed Web of Science ®Google Scholar
• Nayak N. Fungal infections of the eye--laboratory diagnosis and treatment. Nepal Med Coll J. 2008;10:48–63.
   PubMedGoogle Scholar
• Boyd NK, Teng C, Frei CR. Brief overview of approaches and challenges in new antibiotic development: a focus on drug repurposing. Front Cell Infect Microbiol. 2021;11:1–12. doi:10.3389/fcimb.2021.684515
   Web of Science ®Google Scholar
• Nguyen HM, Graber CJ. Limitations of antibiotic options for invasive infections caused by methicillin-resistant Staphylococcus aureus: is combination therapy the answer? J Antimicrob Chemother. 2009;65:24–36. doi:10.1093/jac/dkp377
   Web of Science ®Google Scholar
• Stevens DL, Ma Y, Salmi D, et al. Impact of antibiotics on expression of Virulence-Associated Exotoxin genes in methicillin-sensitive and methicillin-resistant staphylococcus aureus. J Infect Dis. 2007;195:202–211. doi:10.1086/510396
   PubMed Web of Science ®Google Scholar
• Miller LA, Ratnam K, Payne DJ. β - Lactamase-inhibitor combinations in the 21st century: current agents and new developments. Curr Opin Pharmacol. 2001;1:451–458. doi:10.1016/S1471-4892(01)00079-0
   PubMedGoogle Scholar
• Shrestha SK, Fosso MY, Garneau-Tsodikova S. A combination approach to treating fungal infections. Sci Rep. 2015;5:1–11. doi:10.1038/srep17070
   Web of Science ®Google Scholar
• Amin B, Hosseinzadeh H. Black Cumin (Nigella sativa) and Its active constituent, thymoquinone: an overview on the analgesic and anti-inflammatory effects. Planta Med. 2016;82:8–16. doi:10.1055/s-0035-1557838
   PubMed Web of Science ®Google Scholar
• Forouzanfar F, Fazly Bazzaz BS, Hosseinzadeh H. Black cumin (Nigella sativa) and its constituent (thymoquinone): a review on antimicrobial effects. IRAN J BASIC MED SCI. 2014;17:929–938.
   PubMed Web of Science ®Google Scholar
• Almshawit H, Macreadie I. Fungicidal effect of thymoquinone involves generation of oxidative stress in Candida glabrata. Microbiol Res. 2017;195:81–88. doi:10.1016/j.micres.2016.11.008
   PubMedGoogle Scholar
• Elfadil A, et al. The wound healing potential of 2,3 dimethylquinoxaline hydrogel in rat excisional wound model. J Pharm Res Int. 2023;35:1–8. doi:10.9734/jpri/2023/v35i87339
   Google Scholar
• Tan CM, Therien AG, Lu J, et al. Restoring Methicillin-Resistant Staphylococcus aureus Susceptibility to β-Lactam Antibiotics. Sci Transl Med. 2012;4:126ra35. doi:10.1126/scitranslmed.3003592
   PubMed Web of Science ®Google Scholar
• Mikkelsen K, Sirisarn W, Alharbi O, et al. The novel membrane-associated auxiliary factors AuxA and AuxB Modulate β -lactam Resistance in MRSA by stabilizing lipoteichoic acids. Int J Antimicrob Agents. 2021;57:106283. doi:10.1016/j.ijantimicag.2021.106283
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute (CLSI). M07-A9: methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard—Ninth edition; 2002. Available from: https://clsi.org/media/1928/m07ed11_sample.pdf. Accessed May 31, 2024.
   Google Scholar
• Elfadil A, Ibrahem K, Abdullah H, et al. Synergistic Activity of 3-Hydrazinoquinoxaline-2-thiol in combination with penicillin against MRSA. Infect Drug Resist. 2024;17:355–364. doi:10.2147/IDR.S448843
   PubMed Web of Science ®Google Scholar
• Hu Y, Liu Y, Coates A. Azidothymidine produces synergistic activity in combination with colistin against antibiotic-resistant Enterobacteriaceae. Antimicrob Agents Chemother. 2019;63:1–11. doi:10.1128/AAC.01630-18
   Web of Science ®Google Scholar
• Liu X, Pai PJ, Zhang W, et al. Proteomic response of methicillin- resistant S. aureus to a synergistic antibacterial drug combination: a novel erythromycin derivative and oxacillin. Sci Rep. 2016;25:1–12.
   Google Scholar
• Ryder NS, Leitner I. Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species. Med Mycol. 2001;39:91–95. doi:10.1080/mmy.39.1.91.95
   PubMed Web of Science ®Google Scholar
• Kullberg BJ, Arendrup MC. Invasive candidiasis. N Engl J Med. 2015;373:1445–1456. doi:10.1056/NEJMra1315399
   PubMed Web of Science ®Google Scholar
• Bassetti M, Peghin M, Timsit JF. The current treatment landscape: candidiasis. J Antimicrob Chemother. 2016;71:ii13–ii22. doi:10.1093/jac/dkw392
   PubMed Web of Science ®Google Scholar
• Morgan J, Meltzer MI, Plikaytis BD, et al. Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance. Infect Control Hosp Epidemiol. 2005;26:540–547. doi:10.1086/502581
   PubMed Web of Science ®Google Scholar
• Dera AA, Ahmad I, Rajagopalan P, et al. Synergistic efficacies of thymoquinone and standard antibiotics against multi-drug resistant isolates. Saudi Med J. 2021;42:196–204. doi:10.15537/smj.2021.2.25706
   PubMed Web of Science ®Google Scholar
• Mulani MS, Kamble EE, Kumkar SN, Tawre MS, Pardesi KR. Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: a review. Front Microbiol. 2019;10. doi:10.3389/fmicb.2019.00539
   PubMed Web of Science ®Google Scholar
• Gonzales PR, Pesesky MW, Bouley R, et al. Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA. Nat Chem Biol. 2015;11:855–861. doi:10.1038/nchembio.1911
   PubMed Web of Science ®Google Scholar
• Fan Q, Yuan Y, Jia H, et al. Antimicrobial and anti-biofilm activity of thymoquinone against Shigella flexneri. Appl. Microbiol. Biotechnol. 2021;105:4709–4718. doi:10.1007/s00253-021-11295-x
   PubMed Web of Science ®Google Scholar
• Hariharan P, Paul-Satyaseela M, Gnanamani A. In vitro profiling of antimethicillin-resistant Staphylococcus aureus activity of thymoquinone against selected type and clinical strains. Lett Appl Microbiol. 2016;62:283–289. doi:10.1111/lam.12544
   PubMed Web of Science ®Google Scholar
• Phillips IAN. Clinical uses and control of rifampicin and clindamycin. J Clin Pathol. 1971;24:410–418. doi:10.1136/jcp.24.5.410
   PubMed Web of Science ®Google Scholar
• Cheng G, Sa W, Cao C, et al. Quinoxaline 1,4-di-N-oxides: biological activities and mechanisms of actions. Front Pharmacol. 2016;7:1–21. doi:10.3389/fphar.2016.00064
   PubMed Web of Science ®Google Scholar
• Adegbeye MJ, Elghandour MMMY, Faniyi TO, et al. Antimicrobial and antihelminthic impacts of black cumin, pawpaw and mustard seeds in livestock production and health. Agrofor Syst. 2020;94:1255–1268. doi:10.1007/s10457-018-0337-0
   Web of Science ®Google Scholar
• Chacón-Vargas KF, Andrade-Ochoa S, Nogueda-Torres B, et al. Isopropyl quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives induce regulated necrosis-like cell death on Leishmania (Leishmania) mexicana. Parasitol Res. 2018;117:45–58. doi:10.1007/s00436-017-5635-3
   PubMed Web of Science ®Google Scholar
• Rani R, Sharma D, Chaturvedi M, Parkash Yadav J. Antibacterial activity of twenty different endophytic fungi isolated from calotropis procera and time kill assay. Clin Microbiol Open Access. 2017;06. doi:10.4172/2327-5073.1000280
   Google Scholar
• Duan L, Zhang J, Chen Z, et al. Antibiotic combined with epitope-specific monoclonal antibody cocktail protects mice against bacteremia and acute pneumonia from methicillin-resistant staphylococcus aureus infection. J Inflamm Res. 2021;14:4267–4282. doi:10.2147/JIR.S325286
   PubMed Web of Science ®Google Scholar
• Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis. 1998;26:1–12. doi:10.1086/516284
   PubMed Web of Science ®Google Scholar